 In this retrospective study, authors show that relative protection against SARS-CoV-2 infection wanes from 53.4% one month after vaccination to 16.5% three months after vaccination, suggesting that there's a significant waning of mRNA vaccine effectiveness against infection with the Armacron variant. This article was authored by Tal Patalan, Yaki Seishik, Asof Peretz, and others.